Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Shimizu

Showing results (151-160 of 184) with videos related to

Pageof 19
Sort By:
BMC Urology|September 14, 2022
Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)-a prospective single-arm interventional studyMikio Sugimoto, Takuma Kato, Yoichiro Tohi, et al.
Scientific Reports|May 31, 2024
Blood perfusion with polymyxin B immobilized columns in patients with COVID-19 requiring oxygen therapyDaisuke Katagiri, Akinari Tsukada, Shinyu Izumi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 8, 2021
Effect of optimal neoadjuvant chemotherapy on oncological outcomes of locally advanced bladder cancer with laparoscopic radical cystectomy: A matched-pair analysis in a multicenter cohortMasashi Kubota, Toru Kanno, Takahiro Inoue, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 23, 2020
Comparison of single- and multiple-dose cefazolin as prophylaxis for transurethral enucleation of prostate: A multicenter, prospective, randomized controlled trial by the Japanese Research Group for Urinary Tract InfectionYoshikazu Togo, Koji Fukui, Yasuo Ueda, et al.
Urologic Oncology|May 13, 2022
Tolerability and treatment outcome of pembrolizumab in patients with advanced urothelial carcinoma and severe renal dysfunctionYuki Kita, Katsuhiro Ito, Sohei Kanda, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 22, 2020
Perioperative and oncological outcomes of laparoscopic radical cystectomy with intracorporeal versus extracorporeal ileal conduit: A matched-pair comparison in a multicenter cohort in JapanToru Kanno, Takahiro Inoue, Mutsushi Kawakita, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 14, 2022
The efficacy of sequential therapy with docetaxel and cabazitaxel for castration-resistant prostate cancer: A retrospective multi-institutional study in JapanNaoki Terada, Atsuro Sawada, Hiroaki Kawanishi, et al.
Cancer Chemotherapy and Pharmacology|March 22, 2023
A prospective feasibility study of uracil-tegafur and leucovorin as adjuvant chemotherapy for patients aged ≥ 80 years after curative resection of colorectal cancer, the HiSCO-03 studyHiroshi Okuda, Manabu Shimomura, Satoshi Ikeda, et al.
BMC Medical Genetics|July 3, 2020
A case of Turcot's syndrome type 1 with loss of immunoexpression of MSH6 in colon cancer and liver metastasis due to secondary somatic mutation in coding mononucleotide (C)8 tract: a case reportShintaro Akabane, Takao Hinoi, Kiwamu Akagi, et al.
Cureus|March 14, 2025
Inflammatory and Coagulation Marker Changes in PMX-DHP-Treated COVID-19 PatientsAkinari Tsukada, Daisuke Katagiri, Shinyu Izumi, et al.
Pageof 19

Showing results (151-160 of 184) with videos related to

Sort By:
Pageof 19
BMC Urology|September 14, 2022
Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)-a prospective single-arm interventional studyMikio Sugimoto, Takuma Kato, Yoichiro Tohi, et al.
Scientific Reports|May 31, 2024
Blood perfusion with polymyxin B immobilized columns in patients with COVID-19 requiring oxygen therapyDaisuke Katagiri, Akinari Tsukada, Shinyu Izumi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 8, 2021
Effect of optimal neoadjuvant chemotherapy on oncological outcomes of locally advanced bladder cancer with laparoscopic radical cystectomy: A matched-pair analysis in a multicenter cohortMasashi Kubota, Toru Kanno, Takahiro Inoue, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 23, 2020
Comparison of single- and multiple-dose cefazolin as prophylaxis for transurethral enucleation of prostate: A multicenter, prospective, randomized controlled trial by the Japanese Research Group for Urinary Tract InfectionYoshikazu Togo, Koji Fukui, Yasuo Ueda, et al.
Urologic Oncology|May 13, 2022
Tolerability and treatment outcome of pembrolizumab in patients with advanced urothelial carcinoma and severe renal dysfunctionYuki Kita, Katsuhiro Ito, Sohei Kanda, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 22, 2020
Perioperative and oncological outcomes of laparoscopic radical cystectomy with intracorporeal versus extracorporeal ileal conduit: A matched-pair comparison in a multicenter cohort in JapanToru Kanno, Takahiro Inoue, Mutsushi Kawakita, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 14, 2022
The efficacy of sequential therapy with docetaxel and cabazitaxel for castration-resistant prostate cancer: A retrospective multi-institutional study in JapanNaoki Terada, Atsuro Sawada, Hiroaki Kawanishi, et al.
Cancer Chemotherapy and Pharmacology|March 22, 2023
A prospective feasibility study of uracil-tegafur and leucovorin as adjuvant chemotherapy for patients aged ≥ 80 years after curative resection of colorectal cancer, the HiSCO-03 studyHiroshi Okuda, Manabu Shimomura, Satoshi Ikeda, et al.
BMC Medical Genetics|July 3, 2020
A case of Turcot's syndrome type 1 with loss of immunoexpression of MSH6 in colon cancer and liver metastasis due to secondary somatic mutation in coding mononucleotide (C)8 tract: a case reportShintaro Akabane, Takao Hinoi, Kiwamu Akagi, et al.
Cureus|March 14, 2025
Inflammatory and Coagulation Marker Changes in PMX-DHP-Treated COVID-19 PatientsAkinari Tsukada, Daisuke Katagiri, Shinyu Izumi, et al.
Pageof 19